News

A new study has found that linoleic acid, a common fat found in seed oils like soybean and safflower oil, can increase the ...
Artelo Biosciences Inc (NASDAQ:ARTL) saw its stock jump 10% after unveiling encouraging preclinical results for its lead drug ...
Investing.com -- Artelo Biosciences Inc (NASDAQ: ARTL) stock surged 10% following the presentation of positive preclinical data for its lead fatty acid binding protein 5 (FABP5) inhibitor, ART26.12, ...
In these OA studies with ART26.12, the FABP5 inhibitor demonstrated efficacy comparable to naproxen, a commonly prescribed nonsteroidal anti-inflammatory drug (NSAID), with ART26.12 maintaining ...
A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found ...
Artelo Biosciences announces positive Phase 1 results for ART26.12, a novel FABP5 inhibitor for pain management.
Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first-in-class candidate in the field of pain management. The Phase 1 Single Ascending Dose (SAD) study was ...
ART26.12, Artelo's lead FABP5 inhibitor, is being developed as a novel, peripherally acting, non-opioid, non-steroidal analgesic. Data from the first Phase 1 trial with ART26.12 is anticipated in Q2 ...
There's now lots of evidence which shows that our own diets and the foods we eat can influence the outcome if we are unlucky enough to suffer from cancer.
The study also hints that FABP5 might be useful as a biomarker, guiding future nutritional or pharmaceutical interventions for triple-negative breast cancer patients. Additionally, researchers found ...
Feeding mice that model triple-negative breast cancer a high-linoleic-acid diet increased FABP5 levels, mTORC1 activation and tumor growth. The researchers also found increased levels of FABP5 and ...
Hwang discovered that in patient-derived tumor specimens and mouse models of ovarian cancer, FABP5 becomes trapped inside the cytoplasm of T cells instead of moving to the cell surface, where it ...